Nancy McKinstry, CEO and Chairman of the Executive Board, commented:
"Our performance in the third quarter was largely as anticipated, with our
European operations facing a difficult macro-economic environment and our
North
American businesses maintaining their recent momentum. Growth in our
online,
software, and services products globally continues to support overall
positive
organic growth for the group. We are actively managing the portfolio to
drive
faster growth, investing in product innovation and geographic expansion,
and
seeking further operating efficiencies. The quality of the business
continues to
improve and we remain confident we will deliver on our full-year guidance."

Full-Year 2012 Outlook

We reiterate our full-year 2012 guidance, despite worsened conditions in
Europe
and growing uncertainty around the US economy as we enter the fourth
quarter.

Springboard cost savings are on track to reach a run rate of EUR205-EUR210
million
in the full year (compared to EUR191 million in 2011).

Guidance is based on constant exchange rates. Wolters Kluwer generates more
than
half of its ordinary EBITA in North America. As a rule of thumb, based on
our
2011 currency profile, a 1 U.S. cent move in the average EUR/USD exchange
rate
for the year causes an opposite 0.8 euro-cent change in diluted ordinary
EPS.

Net financing costs are expected to be approximately EUR125 million in
constant
currencies. The benchmark effective tax rate on ordinary income before tax
is
expected to be approximately 27.5% in 2012 due to an increasing proportion
of
profits in higher tax regions, such as North America.
Our divisional outlook for 2012 is as follows:

In Legal & Regulatory, we expect European markets to remain challenging in
the
near term. Our North American Legal & Regulatory business is positioned for
growth, although transactional revenue streams have softened in recent
months.
The division's results will reflect two disposals of non-core publishing
operations in the Netherlands which were completed in the second quarter of
2012.

In Tax & Accounting, we continue to expect positive organic growth in the
second
half reflecting seasonal patterns. As indicated in July, we expect the
second-
half margin to be broadly in line with the second half of 2011.

In Health, we expect continued strong demand for Clinical Solutions. Trends
in
journal advertising markets are likely to remain weak. Margins should
benefit
from the ongoing shift towards electronic products. The acquisition of
Health
Language, announced on October 17, is currently expected to close in early
2013.

Wolters Kluwer has a progressive dividend policy under which the company
expects
to increase the dividend per share each year. Shareholders have the option
to
elect dividend pay-out in cash or stock. As per our announcement on July
25,
Wolters Kluwer intends to offset the dilution of its stock dividend and
performance share issuance annually via share repurchases. For the full
year
2012, the company expects to repurchase shares for up to EUR135 million. As
of
November 6, a total of 7.7 million ordinary shares have been repurchased
this
year for a total consideration of EUR100 million (average purchase price
EUR13.07).

Third-Quarter Developments

Third-quarter organic revenue growth was 1%, overall in line with the first
half. Growth in North America and Asia Pacific has been partially offset by
declines in Legal & Regulatory Europe. Total recurring revenues (75% of
group
total) maintained momentum, as growth in electronic and services
subscriptions
more than offset the ongoing decline in print subscriptions. Trends in
books,
transactional and other cyclical products weakened modestly in the quarter.

The third quarter EBITA margin improved slightly and the nine-month margin
was
broadly stable year-on-year, supported by Springboard savings, the ongoing
shift
in business mix, and the favorable effect of currency. Third-quarter cash
flow
from operations increased in constant currencies and the cash conversion
ratio
improved in the quarter compared to the same period a year ago. Ordinary
free
cash flow also increased in constant currencies in the third quarter and
for the
first nine months.

Our net-debt-to-EBITDA ratio (12 month rolling basis) was 2.8x as of
September
30, 2012, improving from 2.9x as of June 30, 2012 and 3.1x at year-end
2011. We
expect to approach our target of 2.5x by the end of this year. This takes
into
account acquisitions completed in the second half, the largest of which was
FinArch.

Legal & Regulatory saw organic revenue trends deteriorate in the third
quarter,
due mainly to weakening trends in loose leafs, books and cyclical products
(training, advertising) across Europe. The North American Legal &
Regulatory
business saw good organic growth in the third quarter, with Law & Business
improving and Corporate Legal Services (CLS) sustaining good momentum
despite
lower transaction volumes associated with M&A, business formation, and
trademark
activities.

Tax & Accounting improved to positive organic growth in the third quarter,
as
anticipated. Growth in North American tax software more than offset
continued
weakness in tax publishing and bank products. European revenues showed
positive
growth in the third quarter, despite the worsened economic conditions.
Growth in
European tax software compensated for declines in loose leaf, book and
cyclical
revenues in the region. In Asia Pacific, revenues declined organically in
the
quarter due mainly to timing of publishing releases in Australia. Acclipse,
which offers online accounting software, including cloud-based solutions
for
finance and tax professionals in Australia, New Zealand, and other parts of
Asia
Pacific, was acquired during the quarter.

Health remains on track to deliver good growth and margin improvement this
year.
Clinical Solutions achieved double-digit organic revenue growth in the
third
quarter, with UpToDate, ProVation Medical and Clinical Drug Information all
performing well. The acquisition of Health Language, currently expected to
close
in early 2013, brings medical terminology management databases and software
that
are highly complimentary to existing Clinical Solutions services. In
Medical
Research, Ovid's growth was positive in the quarter, while our medical
journals
faced continued weakness in advertising markets. Professional & Education
books
achieved growth in the U.S. education segment, but this was offset by
weakness
in medical practice textbooks and international sales.

Financial & Compliance Services organic growth moderated in the third
quarter
from the levels seen in the first half. The full year is still expected to
see
acceleration in growth compared to 2011. Financial Services, which in the
first
half had benefitted from implementation fees from new banking customers,
achieved good organic growth, primarily from products for U.S. mortgage and
lending markets. FRSGlobal achieved double-digit organic growth in the
third
quarter as it continues to roll out globally. The combination with FinArch,
acquired in July, strengthens and extends our capabilities and geographic
reach.
Transport Services, based in Europe, saw continued top line weakness,
particularly in transactional revenues. Audit, Risk & Compliance delivered
strong organic revenue growth as it invests in expansion in Asia and
Central and
South America.

About Wolters Kluwer

Wolters Kluwer is a market-leading global information services company.
Professionals in the areas of legal, business, tax, accounting, finance,
audit,
risk, compliance and healthcare rely on Wolters Kluwer's leading
information-
enabled tools and software solutions to manage their business efficiently,
deliver results to their clients, and succeed in an ever more dynamic
world.

Wolters Kluwer reported 2011 annual revenues of EUR3.4 billion. The group
employs
over 18,500 people worldwide and maintains operations in over 40 countries
across Europe, North America, Asia Pacific and Latin America. The company
is
headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer
shares are
listed on NYSE Euronext Amsterdam (symbol: WKL) and are included in the AEX
and
Euronext 100 indices.

For more information about our products and organization, visit
www.wolterskluwer.com, follow @Wolters_Kluwer on Twitter, or search for
Wolters
Kluwer videos on YouTube.

Should you wish to change how you receive information from Wolters Kluwer,
please click here.

Forward-looking Statements
This press release contains forward-looking statements. These statements
may be
identified by words such as "expect", "should", "could", "shall" and
similar
expressions. Wolters Kluwer cautions that such forward-looking statements
are
qualified by certain risks and uncertainties that could cause actual
results and
events to differ materially from what is contemplated by the forward-
looking
statements. Factors which could cause actual results to differ from these
forward-looking statements may include, without limitation, general
economic
conditions; conditions in the markets in which Wolters Kluwer is engaged;
behavior of customers, suppliers, and competitors; technological
developments;
the implementation and execution of new ICT systems or outsourcing; and
legal,
tax, and regulatory rules affecting Wolters Kluwer's businesses, as well as
risks related to mergers, acquisitions, and divestments. In addition,
financial
risks such as currency movements, interest rate fluctuations, liquidity,
and
credit risks could influence future results. The foregoing list of factors
should not be construed as exhaustive. Wolters Kluwer disclaims any
intention or
obligation to publicly update or revise any forward-looking statements,
whether
as a result of new information, future events or otherwise.